California health centers asked U.S. District Judge John A. Mendez yesterday to stop a state Medicaid drug reimbursement change due to begin tomorrow that they say would strip away all their 340B drug discount savings.
California health centers asked a federal district judge yesterday to stop a major state Medicaid drug reimbursement change due to [...] …
Congress should let the VA negotiate drug prices on behalf of Medicare, U.S. Sen. Joe Manchin (W.Va.) reportedly told the Senate Democratic Caucus this week.
U.S. Sen. Joe Manchin (D-W.Va.) has suggested that the U.S. Department of Veterans Affairs (VA) be empowered to negotiate drug [...] …
Boston-based par8o, which provides 340B services including a platform to help 340B covered entities manage their patient referral claims, has [...] …
The U.S. House Oversight and Reform Committee has issued a blistering report about drug industry pricing and business practices.
The U.S. House Oversight and Reform Committee issued a blistering report late last week accusing brand pharmaceutical manufacturers of systematically [...] …
California health centers plan to seek a court order stopping the state from moving Medicaid managed care drug benefits to Medicaid fee for service on Jan. 1.
As California’s Medicaid program moves toward implementing a fee-for-service payment structure for drug coverage, one of the primary foes of [...] …
GlaxoSmithKline will refund covered entities that purchased certain formulations of a severe asthma treatment in 2022.
Three drug manufacturers recently announced they are refunding 340B overpayments to covered entities, part of a growing number of companies [...] …
Supreme Court Justices announced in a June 10 order that they’d review the U.S. Court of Appeals for the D.C. Circuit’s September 2023 decision in Advocate Christ Medical Center v. Becerra.
340B hospitals’ challenge to Medicare Part B drug reimbursement cuts was not the only case on the U.S. Supreme Court [...] …
Expect Congress to end the fight over contract pharmacy before the 2022 midterm elections, 340B Report Publisher and CEO Ted Slafsky predicts in his latest column for Omnicell.
After five major court decisions on the 340B contract pharmacy standoff and no quick resolution in sight, expect Congress to [...] …
AbbVie’s anti-inflammatory blockbuster Humira accounted for nearly $1.4 billion in additional unsupported U.S. drug spending last year, the Institute for Clinical and Economic Review says.
Makers of seven of 10 top drugs in the U.S. hiked those drugs’ prices substantially in 2020 with no new [...] …
The AHA says a JAMA study on what hospitals charge insurers for clinician-administered drugs lacks context.
The American Hospital Association (AHA) has pushed back on a JAMA Internal Medicine study suggesting that leading acute care facilities [...] …
*Sign up for news summaries and alerts from 340B Report
Copyright © 2025 340B Report, LLC
Reproduction of material from any 340B Report page without written permission is strictly prohibited.
